A study published in the International Journal of Dermatology suggests that oral roflumilast is a safe and effective therapy ...

SAN FRANCISCO, CA / ACCESSWIRE / October 16, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Jaguar ...

Under in-vitro test conditions, dentures fabricated from this proprietary 3D-printing resin have exhibited a >99.9% reduction in the most common bacteria and fungi known to cause biofilm and ...

Researchers from the Interdisciplinary Research Laboratory (LII) of ENES Leon, UNAM, have created an approach for ...

A new directive issued by the Minister of Municipalities Affairs and Agriculture, Wael Al Mubarak, has made it clear: failing ...

Itovebi is supplied as a tablet in 2 dosage strengths: 3 mg and 9 mg. Patients should be selected for treatment based on the presence of 1 or more PIK3CA mutations in plasma specimens. The FDA has ...

VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the program’s potential and validating the VersAptx™ ...

The differential diagnosis includes aphthous stomatitis, varicella, HSV infection and herpangina. Most HFMD cases are self-limiting, and only required supportive treatment. Rarely, there may be a ...

John E. Ganley, D.D.S.

A researcher at the Winthrop P Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), Marius Nagalo, Ph.D., has received the prestigious New Innovator Award from the ...

Used clinically since the 1920s, corticosteroids interrupt multiple steps in immune activation because of the ubiquitous expression of corticosteroid receptors. Corticosteroids inhibit antigen ...